Versartis Lands $21,000,000 Series B Financing Round
Feb 16, 2011 • Deals • TechZulu Inc.
| Company Name | Versartis |
| Information Release Date | 2/16/2011 |
| Transaction Type | Venture Equity |
| Amount | $21,000,000 |
| Round | Series B |
| Proceeds Purpose | Versartis plans to use the proceeds primarily to conduct clinical trials of its lead product, VRS-317, for growth hormone deficiency (GHD) in both adult and pediatric patients. |
